Lifecore Biomedical earnings were -$43.2M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest LFCR earnings report on Jun 30, 2026 announced Q2 2026 earnings of -$7.1M, down 55.3% from last quarter. For the last reported fiscal year 2025 ending May 25, 2025, LFCR reported annual earnings of -$44.4M, with -469.3% growth.
Lifecore Biomedical Earnings Reports & History FAQ
What were Lifecore Biomedical's earnings last quarter?
On LFCR's earnings call on Aug 5, 2026, Lifecore Biomedical (NASDAQ: LFCR) reported Q2 2026 earnings per share (EPS) of -$0.19, up 216.67% year over year. Total LFCR earnings for the quarter were -$7.13 million. In the same quarter last year, Lifecore Biomedical's earnings per share (EPS) was -$0.06.
Is Lifecore Biomedical profitable or losing money?
As of the last Lifecore Biomedical earnings report, Lifecore Biomedical is currently losing money. Lifecore Biomedical's net profit (also called net income) for the twelve months ending Jun 30, 2026 was -$39.10 million, a 0.98% increase year over year.
What was LFCR's earnings growth in the past year?
As of Lifecore Biomedical's earnings date in Aug 5, 2026, Lifecore Biomedical's earnings has grown year over year. LFCR earnings in the past year totalled -$43.19 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.